Plain-English translation of NCT07803055 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying tiny particles found in blood called glial extracellular vesicles, which may help detect Alzheimer's disease earlier and predict how quickly it progresses. This study will follow people across different stages—from those noticing memory problems to those with diagnosed dementia—to understand how these blood markers change over time and what they tell us about brain health.
Currently, detecting Alzheimer's early requires expensive brain scans or risky spinal taps. This research aims to develop a simple blood test that could identify the disease sooner and help doctors predict who will experience cognitive decline, potentially opening doors to earlier treatment.
You likely qualify if…
You likely don't qualify if…
You will visit the research center multiple times over the study period to provide blood samples, undergo memory and thinking tests, and possibly have brain imaging. Researchers will track changes in your blood markers and cognitive function over time to understand how these blood particles relate to Alzheimer's progression. The study may also involve laboratory testing of your blood samples on human brain cells grown in the lab.
AI-generated summary from trial data · Oct 22, 2026 · Not medical advice
Italy